Lotta E. Oikari

741 total citations
22 papers, 441 citations indexed

About

Lotta E. Oikari is a scholar working on Neurology, Molecular Biology and Cell Biology. According to data from OpenAlex, Lotta E. Oikari has authored 22 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Lotta E. Oikari's work include Proteoglycans and glycosaminoglycans research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Alzheimer's disease research and treatments (3 papers). Lotta E. Oikari is often cited by papers focused on Proteoglycans and glycosaminoglycans research (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Alzheimer's disease research and treatments (3 papers). Lotta E. Oikari collaborates with scholars based in Australia, Finland and United Kingdom. Lotta E. Oikari's co-authors include Lyn R. Griffiths, Larisa M. Haupt, Anthony R. White, Jürgen Götz, Romal Stewart, Hazel Quek, André J. van Wijnen, Simon M. Cool, Emily T. Camilleri and Liyu Chen and has published in prestigious journals such as Blood, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Lotta E. Oikari

19 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lotta E. Oikari Australia 12 171 100 78 73 64 22 441
Nuno Jorge Lamas Portugal 10 239 1.4× 91 0.9× 45 0.6× 22 0.3× 45 0.7× 29 442
Junko Okano Japan 12 228 1.3× 127 1.3× 49 0.6× 31 0.4× 76 1.2× 28 557
Amar Sharma United Kingdom 4 326 1.9× 121 1.2× 112 1.4× 102 1.4× 24 0.4× 5 627
Walison N. Silva Brazil 10 146 0.9× 51 0.5× 40 0.5× 30 0.4× 60 0.9× 19 397
Ryan G. Lim United States 11 309 1.8× 173 1.7× 49 0.6× 54 0.7× 32 0.5× 18 565
Harwin Sidik Singapore 10 405 2.4× 73 0.7× 42 0.5× 105 1.4× 70 1.1× 16 618
Sarrabeth Stone United States 15 209 1.2× 103 1.0× 42 0.5× 163 2.2× 31 0.5× 20 561
Beata Werne Solnestam Sweden 8 216 1.3× 60 0.6× 33 0.4× 31 0.4× 39 0.6× 10 484
Simon Gritsch United States 7 131 0.8× 54 0.5× 97 1.2× 17 0.2× 137 2.1× 8 452
Emily R. Lowry United States 9 294 1.7× 29 0.3× 40 0.5× 34 0.5× 91 1.4× 11 499

Countries citing papers authored by Lotta E. Oikari

Since Specialization
Citations

This map shows the geographic impact of Lotta E. Oikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotta E. Oikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotta E. Oikari more than expected).

Fields of papers citing papers by Lotta E. Oikari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotta E. Oikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotta E. Oikari. The network helps show where Lotta E. Oikari may publish in the future.

Co-authorship network of co-authors of Lotta E. Oikari

This figure shows the co-authorship network connecting the top 25 collaborators of Lotta E. Oikari. A scholar is included among the top collaborators of Lotta E. Oikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotta E. Oikari. Lotta E. Oikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gerring, Zachary F., Oneil G. Bhalala, Liam G. Fearnley, et al.. (2025). Drug repurposing candidates for amyotrophic lateral sclerosis using common and rare genetic variants. Brain Communications. 7(3). fcaf184–fcaf184.
2.
Wasielewska, Joanna M., Mauricio Castro Cabral-da-Silva, Martina Pecoraro, et al.. (2024). A patient-derived amyotrophic lateral sclerosis blood-brain barrier model for focused ultrasound-mediated anti-TDP-43 antibody delivery. Fluids and Barriers of the CNS. 21(1). 65–65. 9 indexed citations
3.
Oikari, Lotta E., et al.. (2024). Butyrate and Lauric acid effect on Astrocytes and Neurons in Alzheimer’s disease. Alzheimer s & Dementia. 20(S1). e092277–e092277.
4.
Oikari, Lotta E., Heidi G. Sutherland, Dale R. Nyholt, et al.. (2024). CpG methylation changes in human mesenchymal and neural stem cells in response to in vitro niche modifications. Biochimie. 223. 147–157.
5.
Stewart, Romal, Lotta E. Oikari, Tam Nguyen, et al.. (2024). Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease. Journal of Neuroinflammation. 21(1). 50–50. 12 indexed citations
6.
Stewart, Romal, Joanna M. Wasielewska, Damián Hernández, et al.. (2024). Differential Cytokine Responses of APOE3 and APOE4 Blood–brain Barrier Cell Types to SARS-CoV-2 Spike Proteins. Journal of Neuroimmune Pharmacology. 19(1). 22–22. 2 indexed citations
7.
Dando, Samantha J., et al.. (2023). Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166967–166967. 21 indexed citations
8.
Wasielewska, Joanna M., et al.. (2023). Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound. Neurotherapeutics. 21(1). e00299–e00299. 3 indexed citations
9.
Chen, Liyu, Esteban Cruz, Lotta E. Oikari, et al.. (2022). Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound. Advanced Drug Delivery Reviews. 189. 114517–114517. 23 indexed citations
10.
Oikari, Lotta E., et al.. (2022). Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers. Biochimie. 198. 60–75. 13 indexed citations
11.
Quek, Hazel, Romal Stewart, Tiziana Colletti, et al.. (2022). ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. Journal of Neuroinflammation. 19(1). 58–58. 55 indexed citations
12.
Wasielewska, Joanna M., Rebecca L. Johnston, Damián Hernández, et al.. (2022). A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies. Theranostics. 12(16). 6826–6847. 24 indexed citations
13.
Oikari, Lotta E., Rucha Pandit, Romal Stewart, et al.. (2020). Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery. Stem Cell Reports. 14(5). 924–939. 64 indexed citations
14.
Oikari, Lotta E., et al.. (2020). HSPGs glypican‐1 and glypican‐4 are human neuronal proteins characteristic of different neural phenotypes. Journal of Neuroscience Research. 98(8). 1619–1645. 10 indexed citations
15.
Oikari, Lotta E., et al.. (2018). Heparan Sulfate Proteoglycans as Drivers of Neural Progenitors Derived From Human Mesenchymal Stem Cells. Frontiers in Molecular Neuroscience. 11. 134–134. 14 indexed citations
16.
Oikari, Lotta E., et al.. (2016). Data defining markers of human neural stem cell lineage potential. Data in Brief. 7. 206–215. 18 indexed citations
17.
Oikari, Lotta E., et al.. (2015). Cell surface heparan sulfate proteoglycans as novel markers of human neural stem cell fate determination. Stem Cell Research. 16(1). 92–104. 49 indexed citations
18.
Camilleri, Emily T., Lotta E. Oikari, Simon M. Cool, et al.. (2015). Human Mesenchymal Stem Cells Retain Multilineage Differentiation Capacity Including Neural Marker Expression after Extended In Vitro Expansion. PLoS ONE. 10(9). e0137255–e0137255. 67 indexed citations
19.
Oikari, Lotta E., Shani Stuart, Hannah C. Cox, et al.. (2012). Investigation of lymphotoxin α genetic variants in migraine. Gene. 512(2). 527–531. 9 indexed citations
20.
Tuomela, Soile, Subhash Tripathi, Zhi Chen, et al.. (2012). Identification of early gene expression changes during human Th17 cell differentiation. Blood. 119(23). e151–e160. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuno Jorge Lamas Breakdown of academic impact, for papers by Junko Okano Breakdown of academic impact, for papers by Amar Sharma Breakdown of academic impact, for papers by Walison N. Silva Breakdown of academic impact, for papers by Ryan G. Lim Breakdown of academic impact, for papers by Harwin Sidik Breakdown of academic impact, for papers by Sarrabeth Stone Breakdown of academic impact, for papers by Beata Werne Solnestam Breakdown of academic impact, for papers by Simon Gritsch Breakdown of academic impact, for papers by Emily R. Lowry
Rankless by CCL
2026